![](https://www.texasretina.com/wp-content/uploads/2024/07/Abbey-ASRS-2024.png)
Posted On July 24, 2024 /
By Debbie Muse / Posted in Blog
Ashkan M. Abbey, MD, Presented Real-world Outcomes of Fluocinolone Acetonide Intravitreal Implant for Non-infectious Uveitis at ASRS 2024 Annual Meeting
Texas Retina’s Ashkan M. Abbey, MD, presented “36-month Optical Coherence Tomography Outcomes from CALM: A Registry Evaluating Treatment of Chronic Non-infectious Uveitis with the 0.18 mg Fluocinolone Acetonide Intravitreal Implant” at the
read more![](https://www.texasretina.com/wp-content/uploads/2018/07/David-Callanan-MD.jpg)
Posted On November 8, 2019 /
By Debbie Muse / Posted in Blog
David Callanan, MD, Presented Uveitis Clinical Trial Results at American Society of Retina Specialists 2019 Annual Meeting
Texas Retina Associates’ David Callanan, MD, presented the results of a clinical trial on a promising new treatment for chronic posterior segment uveitis at the American Society of Retina Specialists (ASRS) 2019
read more